Clinical Trial: A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07924930) titled 'A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function' on Nov. 04.

Brief Summary: The main purpose of this study is to measure how much tersolisib gets into the bloodstream and how long it takes the body to eliminate it in participants with kidney impairment compared to those with normal kidney function. The safety of tersolisib will also be evaluated.

For each participant, the study will last about 7 weeks including a 14-night stay in the clinical research unit (CRU) and one follow-up telephone call.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL...